Patent foramen ovale and cryptogenic stroke

Area of Science:

• Cardiology
• Neurology
• Medical Research

Background:

• A patent foramen ovale (PFO) is an atrial septal defect present in approximately 25% of adults.
• PFO has been implicated as a potential risk factor for cryptogenic stroke, a stroke of unknown origin.

Purpose of the Study:

• To review the current understanding of patent foramen ovale (PFO) in relation to cryptogenic stroke.
• To discuss the pathophysiology, diagnostic methods, and therapeutic interventions for patients with PFO and cryptogenic stroke.

Main Methods:

• Literature review of case-control studies and relevant medical research.
• Synthesis of current knowledge on PFO pathophysiology and diagnosis.
• Overview of established and emerging therapeutic options.

Main Results:

• Case-control studies consistently associate PFO with an increased risk of cryptogenic stroke.
• Understanding of PFO pathophysiology is evolving, with several proposed mechanisms for paradoxical embolism.
• Diagnostic modalities include echocardiography (TTE, TEE) and cardiac MRI.

Conclusions:

• PFO is a significant consideration in the workup of cryptogenic stroke.
• Further research is needed to clarify the precise role of PFO and optimize therapeutic strategies.
• Management decisions for PFO in cryptogenic stroke require individualized assessment.